Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2000
11/09/2000WO2000066560A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
11/09/2000WO2000066556A1 Indoline derivatives as progesterone antagonists
11/09/2000WO2000066555A1 Thio-oxindole derivatives
11/09/2000WO2000066554A1 3,3-substituted indoline derivatives
11/09/2000WO2000066224A1 Universal device for preventing respiratory failure, for administering drugs progressively and for curing snoring
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000WO2000066103A2 Contraceptive compositions containing cyclic urea and amide derivatives
11/09/2000WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
11/09/2000WO2000027422A3 Methods and compositions for treating or preventing peripheral neuropathies
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372768A1 Contraceptive compositions containing cyclic urea and amide derivatives
11/09/2000CA2372591A1 Contraceptive compositions containing 3,3-substituted indoline derivatives and uses thereof
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372214A1 Modified exendins and exendin agonists
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000CA2371651A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
11/09/2000CA2371642A1 Cyclic urea and cyclic amide derivatives
11/09/2000CA2371638A1 Indoline derivatives as progesterone antagonists
11/09/2000CA2371633A1 Thio-oxindole derivatives
11/09/2000CA2371273A1 Tetracyclic progesterone receptor modulator compounds and methods
11/09/2000CA2366805A1 Benzimidazolones and analogues and their use as progesterone receptor ligands
11/08/2000EP1049684A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
11/08/2000EP0734396B1 ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY
11/08/2000EP0650495B1 Improved antiandrogens
11/08/2000CN1272789A Pharmaceutical compositions for oral administration of molecular iodine
11/08/2000CN1058177C Traditional Chinese medicine plaster for curing mastosis
11/07/2000US6143779 Benzofuranone derivatives and a method for producing them
11/07/2000US6143755 Pharmaceutical methods of treatment with ACAT inhibitors and HMG-CoA reductase inhibitors
11/07/2000US6143722 To controll uterine contractions in treating preterm labor
11/07/2000US6143306 Methods for treating pancreatic disorders
11/07/2000US6143305 Antigenically modified polypeptides composition
11/07/2000CA2166981C Oncoprotein protein kinase
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000064931A1 A ligand of the protein 'beacon'
11/02/2000WO2000064888A1 Di-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064486A2 Enzymatically activated polymeric drug conjugates
11/02/2000WO2000064485A2 Specifically targeted catalytic antagonists and uses thereof
11/02/2000WO2000064431A1 Pharmaceutical compositions of tetrac and methods of use thereof
11/02/2000WO2000064420A2 Compositions and methods for treating amyloidosis using sulphonate derivatives
11/02/2000WO2000064283A1 Supplement for restoring growth hormone levels
11/02/2000WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
11/02/2000WO2000030622A3 Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
11/02/2000WO1999063973A3 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
11/02/2000EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses
11/02/2000CA2370653A1 Pharmaceutical compositions of tetrac and methods of use thereof
11/02/2000CA2370286A1 A ligand of the protein "beacon"
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2369999A1 Enzymatically activated polymeric drug conjugates
11/02/2000CA2368213A1 Specifically targeted catalytic antagonists and uses thereof
11/01/2000CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition
11/01/2000CN1271593A Medicine for treating thyropathy
11/01/2000CN1058009C 8-oxy-5,8-dihydro-6H-dibenzo [a,g] quinolizine -13-propionic acid derivant, its preparation method and medicinal use thereof
11/01/2000CN1057920C Hyperthyroidism plaster and its preparing method
10/2000
10/31/2000US6140327 Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
10/31/2000US6139839 Administering to warm-blooded animal an effective amount of an immunotherapy agent that binds to and inhibits the growth-regulating activity of chorionic gonadotropin-like growth-regulating protein of infectious microorganism
10/27/2000CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses
10/27/2000CA2306720A1 Supplement for restoring growth hormone levels
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063438A2 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000WO2000063228A1 Ent-steroids as selectively active estrogens
10/26/2000WO2000062797A1 Remedies for autonomic neuropathy
10/26/2000WO2000062778A1 Cyclic protein tyrosine kinase inhibitors
10/26/2000WO2000062774A1 Methods of treating clinical diseases with isoflavones
10/26/2000WO2000062766A2 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/26/2000WO2000062761A1 Process for microencapsulation of water soluble substances
10/26/2000WO2000062759A1 Dry, mouldable drug formulation
10/26/2000WO2000062657A2 Improvement of t cell mediated immunity
10/26/2000WO2000039120A3 Compounds and methods for modulation of estrogen receptors
10/26/2000WO2000031120A3 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
10/26/2000WO2000027815A3 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands
10/26/2000CA2371972A1 Ent-steroids as selectively active estrogens
10/26/2000CA2370945A1 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000CA2370296A1 Improvement of t cell mediated immunity
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2369808A1 Process for microencapsulation of water soluble substances
10/26/2000CA2368784A1 Methods of treating clinical diseases with isoflavones
10/25/2000EP1045908A2 Human urotensin ii
10/25/2000EP0736039B1 Compounds with growth hormone releasing properties
10/25/2000CN1271285A Remedial agent for baldness and other diseases
10/25/2000CN1271279A Amide derivatives for the treatment of diseases mediated by cytokines
10/25/2000CN1270960A Process for preparing growth hormone cinogenic agent
10/25/2000CN1270822A Chinese medicine for treating puerperal diseases
10/25/2000CN1057770C Application of 19,11 beta-bridged sterodal compound in pharmaceutical working
10/25/2000CN1057769C Process for preparing 14 alpha, 17 alpha-bridged ethano-16 alpha-hydroxy-estratrienes medicinal compositions
10/25/2000CN1057673C Tablet, capsule, or granule comprising desogestrel
10/24/2000US6136953 Human antiproliferative polypeptide for the detection of vascular injuries
10/24/2000US6136845 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl PCDFs
10/24/2000US6136563 With defined substitutions for enhanced affinity for its receptor
10/19/2000WO2000061757A1 Tumor necrosis factor homologs and nucleic acids encoding the same
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061622A2 Genes associated with diseases of the kidney
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061608A2 Low-molecular inhibitors of complement proteases
10/19/2000WO2000061587A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
10/19/2000WO2000061586A1 Bicyclic heteroaromatic compounds useful as lh agonists
10/19/2000WO2000061545A1 Methods for solid phase combinatorial synthesis of integrin inhibitors
10/19/2000WO2000061178A1 Pulmonary administration of dry powder formulations for treating infertility
10/19/2000WO2000061112A2 Solubilized pharmaceutical composition for parenteral administration
10/19/2000WO2000037103A3 Compounds for intracellular delivery of therapeutic moieties to nerve cells
1 ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 ... 290